Sangamo Therapeutics
SGMO
S$0.73
Share price
-5.02%
Change (1 day)
-40.56%
Change (1 year)
Market capitalization of Sangamo Therapeutics (SGMO)
Market cap: S$0.18 Billion
As of July 2025 Sangamo Therapeutics has a market cap of S$0.18 Billion. This makes Sangamo Therapeutics the world's 8958th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sangamo Therapeutics from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$0.18 B | -75.2% |
| 2024 | S$0.72 B | 470.55% |
| 2023 | S$0.12 B | -81.55% |
| 2022 | S$0.68 B | -53.3% |
| 2021 | S$1.47 B | -49.42% |
| 2020 | S$2.91 B | 123.13% |
| 2019 | S$1.30 B | -18.34% |
| 2018 | S$1.60 B | -13.56% |
| 2017 | S$1.85 B | 494.69% |
| 2016 | S$0.31 B | -65.69% |
| 2015 | S$0.90 B | -34.54% |
| 2014 | S$1.38 B | 26.71% |
| 2013 | S$1.09 B | 180.9% |
| 2012 | S$0.38 B | 102.06% |
| 2011 | S$0.19 B | -50.28% |
| 2010 | S$0.38 B | 3.79% |
| 2009 | S$0.37 B | 83.36% |
| 2008 | S$0.20 B | -73% |
| 2007 | S$0.75 B | 112.98% |
| 2006 | S$0.35 B | 72.9% |
| 2005 | S$0.20 B | -17.07% |
| 2004 | S$0.24 B | 6.66% |
| 2003 | S$0.23 B | 79.48% |
| 2002 | S$0.12 B | -69.47% |
| 2001 | S$0.42 B | -43.45% |
| 2000 | S$0.74 B |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of Sangamo Therapeutics was reported to be:
S$0.17 Billion
S$0.18 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | S$182.95 B | 101,501.33% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | S$55.49 B | 30,717.54% | 🇺🇸 USA |
 Amgen AMGN | S$210.16 B | 116,611.24% | 🇺🇸 USA |
 Biogen BIIB | S$24.12 B | 13,300.30% | 🇺🇸 USA |
 Dow DOW | S$22.98 B | 12,662.32% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$521.28 B | 289,390.70% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | S$14.37 B | 7,884.80% | 🇺🇸 USA |
 Merck MRK | S$267.14 B | 148,258.66% | 🇺🇸 USA |